{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:09:02Z","timestamp":1775714942760,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1124\/jpet.114.222356","type":"journal-article","created":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T07:18:39Z","timestamp":1423207119000},"page":"102-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Interactions between Bupropion and 3,4-Methylenedioxymethamphetamine in Healthy Subjects"],"prefix":"10.1016","volume":"353","author":[{"given":"Yasmin","family":"Schmid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Rickli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Schaffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urs","family":"Duthaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Grouzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9dric M.","family":"Hysek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias E.","family":"Liechti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.222356_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0014-2999(89)90363-4","article-title":"The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action","volume":"166","author":"Andersen","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.114.222356_bib2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/mol.104.001313","article-title":"Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors","volume":"66","author":"Damaj","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.114.222356_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fgene.2012.00235","article-title":"MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?","volume":"3","author":"de la Torre","year":"2012","journal-title":"Front Genet"},{"key":"10.1124\/jpet.114.222356_bib4","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1021\/ac4004584","article-title":"High-throughput and sensitive quantitation of plasma catecholamines by ultraperformance liquid chromatography-tandem mass spectrometry using a solid phase microwell extraction plate","volume":"85","author":"Dunand","year":"2013","journal-title":"Anal Chem"},{"key":"10.1124\/jpet.114.222356_bib5","first-page":"3009","article-title":"Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines","volume":"80","author":"Eisenhofer","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.114.222356_bib6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.npp.1301481","article-title":"Bupropion for the treatment of methamphetamine dependence","volume":"33","author":"Elkashef","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.114.222356_bib7","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1152\/physrev.1990.70.4.963","article-title":"Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions","volume":"70","author":"Esler","year":"1990","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.114.222356_bib8","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.107.129056","article-title":"Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics","volume":"323","author":"Farr\u00e9","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.222356_bib9","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1373\/clinchem.2008.107193","article-title":"Neuronal source of plasma dopamine","volume":"54","author":"Goldstein","year":"2008","journal-title":"Clin Chem"},{"key":"10.1124\/jpet.114.222356_bib10","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/sleep\/32.11.1425","article-title":"The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents","volume":"32","author":"Gruner","year":"2009","journal-title":"Sleep"},{"key":"10.1124\/jpet.114.222356_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuropharm.2014.06.012","article-title":"Dopamine reuptake transporter (DAT) \u201cinverse agonism\u201d\u2014a novel hypothesis to explain the enigmatic pharmacology of cocaine","volume":"87","author":"Heal","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.114.222356_bib12","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/add.12636","article-title":"Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use","volume":"109","author":"Heinzerling","year":"2014","journal-title":"Addiction"},{"key":"10.1124\/jpet.114.222356_bib13","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0026-895X(24)12046-9","article-title":"CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants","volume":"28","author":"Hesse","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.114.222356_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.2013.2","article-title":"Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants","volume":"93","author":"Hicks","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.114.222356_bib15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1124\/jpet.111.188425","article-title":"Effects of the \u03b1\u2082-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers","volume":"340","author":"Hysek","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.222356_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00213-012-2645-9","article-title":"MDMA enhances \u201cmind reading\u201d of positive emotions and impairs \u201cmind reading\u201d of negative emotions","volume":"222","author":"Hysek","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.114.222356_bib17","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/JCP.0b013e3182979d32","article-title":"a-Adrenergic receptors contribute to the acute effects of 3,4-methtlenedioxymethamphetamine in humans","volume":"33","author":"Hysek","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/jpet.114.222356_bib18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00213-012-2761-6","article-title":"Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex","volume":"224","author":"Hysek","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.114.222356_bib19","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1111\/j.1476-5381.2012.01936.x","article-title":"Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans","volume":"166","author":"Hysek","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.114.222356_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/clpt.2011.78","article-title":"The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (\u201cecstasy\u201d) in humans","volume":"90","author":"Hysek","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.114.222356_bib21","doi-asserted-by":"crossref","first-page":"e36476","DOI":"10.1371\/journal.pone.0036476","article-title":"Duloxetine inhibits effects of MDMA (\u201cecstasy\u201d) in vitro and in humans in a randomized placebo-controlled laboratory study","volume":"7","author":"Hysek","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1124\/jpet.114.222356_bib22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S1461145713001132","article-title":"Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination","volume":"17","author":"Hysek","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/jpet.114.222356_bib23","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.clinthera.2005.11.011","article-title":"Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations","volume":"27","author":"Jefferson","year":"2005","journal-title":"Clin Ther"},{"key":"10.1124\/jpet.114.222356_bib24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/0091270008314254","article-title":"Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity","volume":"48","author":"Kharasch","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.114.222356_bib25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/01.jcp.0000162805.46453.e3","article-title":"Inhibition of CYP2D6 activity by bupropion","volume":"25","author":"Kotlyar","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/jpet.114.222356_bib26","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/S0006-2952(00)00284-7","article-title":"Identification of the human cytochromes P450 involved in the oxidative metabolism of \u201cEcstasy\u201d-related designer drugs","volume":"59","author":"Kreth","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.114.222356_bib27","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0006-3223(02)01834-6","article-title":"In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography","volume":"54","author":"Learned-Coughlin","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.114.222356_bib28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0893-133X(99)00148-7","article-title":"Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d) are attenuated by the serotonin uptake inhibitor citalopram","volume":"22","author":"Liechti","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.114.222356_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/026988110001400313","article-title":"The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine (\u2018Ecstasy\u2019) in healthy volunteers","volume":"14","author":"Liechti","year":"2000","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.114.222356_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1124\/jpet.114.214288","article-title":"Differential substitution for the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and methylphenidate in rats","volume":"350","author":"Mori","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.222356_bib31","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.psyneuen.2013.03.003","article-title":"Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice","volume":"38","author":"Neumann","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1124\/jpet.114.222356_bib32","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00213-005-0102-8","article-title":"Safety of intravenous methamphetamine administration during treatment with bupropion","volume":"182","author":"Newton","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.114.222356_bib33","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.npp.1300979","article-title":"Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving","volume":"31","author":"Newton","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.114.222356_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0376-8716(00)00198-8","article-title":"Effects of cocaine prior to and during bupropion maintenance in cocaine-abusing volunteers","volume":"63","author":"Oliveto","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.114.222356_bib35","first-page":"202","article-title":"Psychopharmacology of bupropion in normal volunteers","volume":"44","author":"Peck","year":"1983","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/jpet.114.222356_bib36","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1124\/dmd.107.020198","article-title":"An in vitro mechanistic study to elucidate the desipramine\/bupropion clinical drug-drug interaction","volume":"36","author":"Reese","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.114.222356_bib37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drugalcdep.2008.09.006","article-title":"Bupropion attenuates methamphetamine self-administration in adult male rats","volume":"100","author":"Reichel","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.114.222356_bib38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0014-2999(84)90403-5","article-title":"Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake","volume":"104","author":"Richelson","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.114.222356_bib39","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/sj.npp.1301161","article-title":"Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice","volume":"31","author":"Risbrough","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.114.222356_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0022432","article-title":"Comparison of the effects of methamphetamine, bupropion, and methylphenidate on the self-administration of methamphetamine by rhesus monkeys","volume":"19","author":"Schindler","year":"2011","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.114.222356_bib41","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/0269881114542454","article-title":"Differential effects of MDMA and methylphenidate on social cognition","volume":"28","author":"Schmid","year":"2014","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.114.222356_bib42","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003088-200544060-00006","article-title":"Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe","volume":"44","author":"Segura","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.114.222356_bib43","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.114.222356_bib44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bcp.2014.01.024","article-title":"Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives","volume":"88","author":"Simmler","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.114.222356_bib45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1756-0500-6-220","article-title":"Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence (Abstract)","volume":"6","author":"Simmler","year":"2013","journal-title":"BMC Res Notes"},{"key":"10.1124\/jpet.114.222356_bib46","first-page":"159","article-title":"A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor","volume":"6","author":"Stahl","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1124\/jpet.114.222356_bib47","doi-asserted-by":"crossref","unstructured":"Steuer AE, Schmidhauser C, Liechti ME, Kraemer T (2014) Development and validation of an LC-MS\/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy-methamphetamine (MDMA) and its phase I and II metabolites in human blood plasma. Drug Test Anal 10.1002\/dta.1740.","DOI":"10.1002\/dta.1740"},{"key":"10.1124\/jpet.114.222356_bib48","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00213-006-0576-z","article-title":"The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans","volume":"189","author":"Tancer","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.114.222356_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000336551","article-title":"The discrimiminatory value of CYP2D6 genotyping in predicting the dextromethorphan\/dextrorphan phenotype in women with breast cancer","volume":"7","author":"Trojan","year":"2012","journal-title":"Breast Care (Basel)"},{"key":"10.1124\/jpet.114.222356_bib50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/0269881107083639","article-title":"MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine\/norepinephrine transport inhibitor","volume":"22","author":"Verrico","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.114.222356_bib51","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00213-005-0174-5","article-title":"MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment","volume":"189","author":"Verrico","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.114.222356_bib52","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0091-3057(02)00818-3","article-title":"Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase","volume":"73","author":"White","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.114.222356_bib53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF03033808","article-title":"Dopamine and reward: the anhedonia hypothesis 30 years on","volume":"14","author":"Wise","year":"2008","journal-title":"Neurotox Res"},{"key":"10.1124\/jpet.114.222356_bib54","series-title":"Die Beschwerden-Liste","author":"Zerssen","year":"1976"},{"key":"10.1124\/jpet.114.222356_bib55","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/clpt.2012.186","article-title":"CYP2B6 and bupropion\u2019s smoking-cessation pharmacology: the role of hydroxybupropion","volume":"92","author":"Zhu","year":"2012","journal-title":"Clin Pharmacol Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418977X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418977X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.222356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:58:16Z","timestamp":1739987896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652418977X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S002235652418977X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.222356","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions between Bupropion and 3,4-Methylenedioxymethamphetamine in Healthy Subjects","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.222356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}